Next Generation Diabetes Therapy and Drug Delivery Market in U.S. Boosts the Healthcare Industry with Highest CAGR of 33.0% by 2023

Increase in prevalence of diabetes, surge in disposable income, rise in healthcare expenditure, and the advantages of adopting next generation diabetes products over conventional ones drive the growth of the U.S. next generation diabetes therapy and drug delivery market. Additionally, developing products with fewer side effects at affordable prices and the high undiagnosed diabetes patient population provide lucrative opportunities to emerging market players. However, high cost and less variability of products along with a lack of awareness hamper market growth

U.S. Next Generation Diabetes Therapy and Drug Delivery Market generated $446 million in 2015 and is anticipated to garner $6,510 Million by 2023, growing at a CAGR of 33.0% during the forecast period, 2017-2023.

The market is further bifurcated into type I and type II diabetes based on indication, with the type II diabetes segment expected to grow at the fastest rate, registering a CAGR of 33.1% during the forecast period. Based on end user, the market is categorized into diagnostics/clinic, ICU, and home healthcare. The diagnostics/clinics segment generated the highest revenue in 2016 and is projected to continue its dominance from 2017 to 2023, owing to an increase in procurement of the products from diagnostics and clinics by diabetic patients. Meanwhile, the home healthcare segment is poised to grow at the highest rate through 2023.

Get Sample Copy of Report @ https://www.alliedmarketresearch.com/request-sample/4621

Increase in prevalence of diabetes, surge in disposable income, rise in healthcare expenditure, and the advantages of adopting next generation diabetes products over conventional ones drive the growth of the U.S. next generation diabetes therapy and drug delivery market. Additionally, developing products with fewer side effects at affordable prices and the high undiagnosed diabetes patient population provide lucrative opportunities to emerging market players. However, high cost and less variability of products along with a lack of awareness hamper market growth.

Top Key Players :

Abbott Laboratories
Echo Therapeutics Inc.
Hoffmann-La Roche Ltd.
GlySens Incorporated
Medtronic Plc
Sanofi
Novo Nordisk
MannKind Corporation
Dexcom Inc.
Senseonics Holding
They have adopted various strategies such as mergers & acquisitions, collaborations, partnerships, and others to gain a strong position in the industry.

Send Enquiry On Report @ https://www.alliedmarketresearch.com/purchase-enquiry/4621

About us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.